Eli Lilly Announces New Version Of Zepbound With A Month’s Worth Of Doses In KwikPen — How Much Will It Cost?

The new Zepbound KwikPen can be purchased by cash-paying customers through LillyDirect, Eli Lilly’s direct-to-customer website.

📰 Article Image

A sign with the company logo sits outside of the headquarters campus of Eli Lilly and Company on March 17, 2024 in Indianapolis, Indiana. (Photo by Scott Olson/Getty Images)

👤

Rounak Jain · Stocktwits

Published Feb 23, 2026, 2:15 PM

LLY

Eli Lilly and Co. (LLY) on Monday announced a new version of its blockbuster weight-loss drug Zepbound, available in a KwikPen with a month’s supply.

The new Zepbound KwikPen can be purchased by cash-paying customers through LillyDirect, Eli Lilly’s direct-to-customer website. The new Zepbound KwikPen starts at $299 for the lowest dose.

Eli Lilly shares were up nearly 4% in Monday’s pre-market trade. Retail sentiment on Stocktwits around the company trended in the ‘bearish’ territory at the time of writing.

Get updates to this story developing directly on Stocktwits.

Also See: Why Is NVO Stock Falling Pre-Market Today?

For updates and corrections, email newsroom[at]stocktwits[dot]com.

TrendingPremarketLarge CapEquities